Results per Page:
Glitch to switch: Turning spliceosome mutations into immune targets
From the Bleakley Lab, Translational Science and Therapeutics Division
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Safety and feasibility approved for new therapy to treat relapsed hematologic malignancies
From the Bleakley Lab, Translational Science & Therapeutics Division
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
No immature cells allowed – removing naïve T-cells in hematopoietic stem cell transplants
From the Bleakley Lab, Clinical Research Division
Novel transplant approach improves the odds for leukemia patients
Naïve T cells that lead to graft-vs.-host disease removed with magnets
Short H2A histones, part II: a natural-born oncogene lurking in our genomes
From the Malik, Henikoff, Bleakley, and Bradley labs, Basic Sciences Division
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion
Dr. Marie Bleakley named Gerdin Family Endowed Chair for Leukemia Research
Pediatric cancer physician-scientist feted at rooftop reception
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
What’s new in combatting chronic graft-vs.-host disease
Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects
Cancer survivor Rose Ibarra to be honored by Fred Hutch and Mariners at Safeco Field
Cancer survivor Rose Ibarra to be honored by Fred Hutch and Mariners at Safeco Field
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Good News: Innovator award to Dr. Marie Bleakley for new leukemia immunotherapies
Celebrating faculty and staff achievements
Sorting stem cells before transplant helps lower risk of graft-vs.-host disease, researcher reports at ASH
Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports
'Kids are not little adults'
Why children with cancer need their own drugs and their own research